HPV Vaccine Reduces Rate of Cancer-Causing Virus

LINDA MARSA

首页> 外文期刊>Discover >HPV Vaccine Reduces Rate of Cancer-Causing Virus

【24h】

HPV Vaccine Reduces Rate of Cancer-Causing Virus

机译：HPV疫苗可降低致癌病毒的发生率

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

The HPV vaccine prevents the spread of the cancer-causing human papillomavirus. But because HPV is transmitted through sexual contact, some critics say the vaccine promotes promiscuity; others fret about potential side effects. As a result, only a third of teenage girls in the U.S. have received the three recommended shots. So public health officials were surprised when a nationwide survey revealed in June that infection rates from cancer-causing HPV strains have sharply declined since the vaccine was introduced in 2006.

机译：HPV疫苗可防止引起癌症的人乳头瘤病毒传播。但是由于HPV是通过性接触传播的，一些批评家说这种疫苗会促进滥交。其他人担心潜在的副作用。结果，在美国只有三分之一的少女收到了三张推荐的照片。因此，当六月份的一项全国调查显示，自从2006年推出该疫苗以来，致癌的HPV株引起的感染率急剧下降，公共卫生官员对此感到惊讶。

著录项

来源
《Discover》 |2014年第1期|44-44|共1页
作者
LINDA MARSA;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. A single dose of quadrivalent human papillomavirus (HPV) vaccine is immunogenic and reduces HPV detection rates in young women in Mongolia, six years after vaccination [J] . Vaccine . 2020,第27期

机译：单一剂量的四轮脑乳头瘤病毒（HPV）疫苗是免疫原性的，减少疫苗六年蒙古的年轻女性中的HPV检测率
2. Assessment of HPV 16 and HPV 18 antibody responses by pseudovirus neutralization, Merck cLIA and Merck total IgG LIA immunoassays in a reduced dosage quadrivalent HPV vaccine trial [J] . Krajden Mel, Cook Darrel, Yu Amanda, Vaccine . 2014,第5期

机译：通过伪病毒中和，默克cLIA和默克总IgG LIA免疫测定在减量四价HPV疫苗试验中评估HPV 16和HPV 18抗体反应
3. Assessment of HPV 16 and HPV 18 antibody responses by pseudovirus neutralization, Merck cLIA and Merck total IgG LIA immunoassays in a reduced dosage quadrivalent HPV vaccine trial [J] . Krajden Mel, Cook Darrel, Yu Amanda, Vaccine . 2014,第5期

机译：通过伪病毒中和，默克cLIA和默克总IgG LIA免疫测定在减量四价HPV疫苗试验中评估HPV 16和HPV 18抗体反应
4. Structural Characterization of L1 Virus-Like Particles Used as Antigens in Cervarix~(TM) , the HPV-16 and HPV-18 Vaccine against Cervical Cancer [C] . M. Deschuyteneer, A. Miseur Microscopy and microanalysis.;Microscopy and microanalysis. . -1

机译：用于宫颈癌的Cervarix〜（TM），HPV-16和HPV-18疫苗中用作抗原的L1病毒样颗粒的结构表征
5. Prevention of human papillomavirus (HPV) infection and HPV-related diseases: Barriers to HPV vaccine coverage among university women in the U.S., and Initial steps in integrating cervical cytology testing into primary care in the Republic of Georgia. [D] . Bednarczyk, Robert A. 2010

机译：预防人乳头瘤病毒（HPV）感染和与HPV相关的疾病：美国大学女性中HPV疫苗覆盖率的障碍，以及在佐治亚州将宫颈细胞学检测纳入初级保健的初始步骤。
6. Comparison of the immunogenicity of the human papillomavirus (HPV)-16/18 vaccine and the HPV-6/11/16/18 vaccine for oncogenic non-vaccine types HPV-31 and HPV-45 in healthy women aged 18–45 years [O] . Mark H Einstein, Mira Baron, Myron J Levin, 2011

机译：人乳头瘤病毒（HPV）-16/18疫苗和HPV-6 / 11/16/18疫苗对18-45岁健康女性非致癌型HPV-31和HPV-45疫苗的免疫原性比较
7. Vaccine Effectiveness Following Routine Immunization With Bivalent Human Papillomavirus (HPV) Vaccine: Protection Against Incident Genital HPV Infections From a Reduced-Dosing Schedule [O] . Joske Hoes, Audrey J King, Tessa M Schurink-van’t Klooster, 2021

机译：用二价管乳头瘤病毒（HPV）疫苗（HPV）常规免疫疫苗效果：免受来自减少调度时间表的事件生殖器HPV感染的保护

HPV Vaccine Reduces Rate of Cancer-Causing Virus

摘要

著录项

相似文献

相关主题

期刊订阅